{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:49:45Z","timestamp":1783111785566,"version":"3.54.6"},"reference-count":56,"publisher":"Society of Nuclear Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med. Technol."],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.2967\/jnmt.123.265492","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T14:10:34Z","timestamp":1685715034000},"page":"102-116","source":"Crossref","is-referenced-by-count":13,"title":["Cardiac Amyloidosis Imaging, Part 3: Interpretation, Diagnosis, and Treatment"],"prefix":"10.2967","volume":"51","author":[{"given":"Scott","family":"Jerome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Embry-Dierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Schockling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"2023061207251116000_51.2.102.1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.245381"},{"key":"2023061207251116000_51.2.102.2","unstructured":"Rare disease. National Cancer Institute website. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/rare-disease. Accessed April 19, 2023."},{"key":"2023061207251116000_51.2.102.3","doi-asserted-by":"crossref","first-page":"e006075","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","article-title":"Expert consensus recommendations for suspicion and diagnosis of transthyretin cardiac amyloidosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ Heart Fail."},{"key":"2023061207251116000_51.2.102.4","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000792"},{"key":"2023061207251116000_51.2.102.5","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1001\/jama.2020.15566","article-title":"Heart failure with preserved ejection fraction: time for reset","volume":"324","author":"Clark","year":"2020","journal-title":"JAMA."},{"key":"2023061207251116000_51.2.102.6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv338"},{"key":"2023061207251116000_51.2.102.7","first-page":"83","article-title":"Cardiac amyloidosis imaging, part 1: etiology and acquisition","volume":"51","author":"Embry-Dierson","year":"2023","journal-title":"J Nucl Technol Imaging."},{"key":"2023061207251116000_51.2.102.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.123.265416"},{"key":"2023061207251116000_51.2.102.9","unstructured":"Amyloidosis. Yale Medicine website. https:\/\/www.yalemedicine.org\/conditions\/amyloidosis. Accessed April 19, 2023."},{"key":"2023061207251116000_51.2.102.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2019.04.010"},{"key":"2023061207251116000_51.2.102.11","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.84.s3.02"},{"key":"2023061207251116000_51.2.102.12","doi-asserted-by":"crossref","first-page":"13158","DOI":"10.3390\/ijms222313158","article-title":"A brief journey through protein misfolding in transthyretin amyloidosis (ATTR amyloidosis)","volume":"22","author":"Gonzalez-Duarte","year":"2021","journal-title":"Int J Mol Sci."},{"key":"2023061207251116000_51.2.102.13","unstructured":"Cardiac amyloidosis. Yale Medicine website. https:\/\/www.yalemedicine.org\/conditions\/cardiac-amyloidosis. Accessed April 19, 2023."},{"key":"2023061207251116000_51.2.102.14","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1177\/2047487319884371","article-title":"Red flags in cardiac amyloidosis","volume":"27","author":"Kwok","year":"2020","journal-title":"Eur J Prev Cardiol."},{"key":"2023061207251116000_51.2.102.15","unstructured":"Neuropathy in amyloidosis. Amyloidosis Research Consortium website. https:\/\/arci.org\/wp-content\/uploads\/2022\/06\/Neuropathy-in-Amyloidosis.pdf. Published 2022. Accessed April 19, 2023."},{"key":"2023061207251116000_51.2.102.16","doi-asserted-by":"crossref","unstructured":"Rodriguez FJ Picken MM Lee JM . Amyloid deposition in central nervous system. In: Picken MM Herrera GA Dogan A , eds. Amyloid and Related Disorders: Surgical Pathology and Clinical Correlations. Humana Press; 2015:121\u2013131.","DOI":"10.1007\/978-3-319-19294-9_8"},{"key":"2023061207251116000_51.2.102.17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ejhf.1742","article-title":"Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across spectrum of aetiologies","volume":"22","author":"Milandri","year":"2020","journal-title":"Eur J Heart Fail."},{"key":"2023061207251116000_51.2.102.18","unstructured":"Transthyretin cardiac amyloidosis: frequently asked questions. American Society of Nuclear Cardiology website. https:\/\/www.asnc.org\/files\/transthyretin_FAQ.pdf. Published July 2021. Accessed April 19, 2023."},{"key":"2023061207251116000_51.2.102.19","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2015.1135792"},{"key":"2023061207251116000_51.2.102.20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12891-020-03912-z","article-title":"Musculoskeletal pathology as early warning sign of systemic amyloidosis: systematic review of amyloid deposition and orthopedic surgery","volume":"22","author":"Wininger","year":"2021","journal-title":"BMC Musculoskelet Disord."},{"key":"2023061207251116000_51.2.102.21","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006050460"},{"key":"2023061207251116000_51.2.102.22","unstructured":"Aung T Coulson I . Systemic amyloidosis. DermNet website. https:\/\/dermnetnz.org\/topics\/systemic-amyloidosis. Published June 2022. Accessed April 19, 2023."},{"key":"2023061207251116000_51.2.102.23","unstructured":"Goshe J . Amyloidosis has variety of ophthalmological manifestations. Healio website. https:\/\/www.healio.com\/news\/ophthalmology\/20120331\/amyloidosis-has\u2013variety-of-ophthalmological-manifestations. November 22, 2011. Accessed April 19, 2023."},{"key":"2023061207251116000_51.2.102.24","unstructured":"Heid M . What makes diagnosing amyloidosis so difficult? Everyday Health website. https:\/\/www.everydayhealth.com\/amyloidosis\/diagnosis\/. Published November 13, 2022. Accessed April 19, 2023."},{"key":"2023061207251116000_51.2.102.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.07.026"},{"key":"2023061207251116000_51.2.102.26","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur Heart J."},{"key":"2023061207251116000_51.2.102.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.04.033"},{"key":"2023061207251116000_51.2.102.28","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.120.052136","article-title":"Prevalence of atrial fibrillation and thromboembolic risk in wild-type transthyretin amyloid cardiomyopathy","volume":"143","author":"Bukhari","year":"2021","journal-title":"Circulation."},{"key":"2023061207251116000_51.2.102.29","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.19102\/icrm.2018.090301","article-title":"Arrhythmias in cardiac amyloidosis","volume":"9","author":"John","year":"2018","journal-title":"J Innov Card Rhythm Manag."},{"key":"2023061207251116000_51.2.102.30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi","year":"2018","journal-title":"Trends Cardiovasc Med."},{"key":"2023061207251116000_51.2.102.31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.489187"},{"key":"2023061207251116000_51.2.102.32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12350-018-01552-4","article-title":"State-of\u2013art radionuclide imaging in cardiac transthyretin amyloidosis","volume":"26","author":"Singh","year":"2019","journal-title":"J Nucl Cardiol."},{"key":"2023061207251116000_51.2.102.33","unstructured":"ASNC cardiac amyloidosis practice points: 99mtechnetium-pyrophosphate imaging for transthyretin cardiac amyloidosis. American Society of Nuclear Cardiology website. https:\/\/www.asnc.org\/files\/19110%20ASNC%20Amyloid%20Practice%20Points%20WEB(2).pdf. Published February 2016. Updated February 2019. Accessed April 19, 2023."},{"key":"2023061207251116000_51.2.102.34","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol."},{"key":"2023061207251116000_51.2.102.35","first-page":"e000029","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2\u2014evidence base and standardized methods of imaging","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ Cardiovasc Imaging."},{"key":"2023061207251116000_51.2.102.36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.10.4299"},{"key":"2023061207251116000_51.2.102.37","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s12350-016-0478-3","article-title":"National patterns in imaging utilization for diagnosis of cardiac amyloidosis: focus on Tc99m-pyrophosphate scintigraphy","volume":"24","author":"Harb","year":"2017","journal-title":"J Nucl Cardiol."},{"key":"2023061207251116000_51.2.102.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.022"},{"key":"2023061207251116000_51.2.102.39","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s12350-020-02455-z","article-title":"Addendum to ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2\u2014evidence base and standardized methods of imaging","volume":"28","author":"Dorbala","year":"2021","journal-title":"J Nucl Cardiol."},{"key":"2023061207251116000_51.2.102.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.05.073"},{"key":"2023061207251116000_51.2.102.41","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","article-title":"Prognostic utility of Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid","volume":"18","author":"Hutt","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"2023061207251116000_51.2.102.42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.112.000132"},{"key":"2023061207251116000_51.2.102.43","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12350-020-02328-5","article-title":"Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: perils and pitfalls","volume":"28","author":"Asif","year":"2021","journal-title":"J Nucl Cardiol."},{"key":"2023061207251116000_51.2.102.44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12350-020-02503-8","article-title":"Optimal interpretation of Tc99m PYP in 2020: avoiding million-dollar mistake","volume":"28","author":"Gerber","year":"2021","journal-title":"J Nucl Cardiol."},{"key":"2023061207251116000_51.2.102.45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12350-013-9803-2","article-title":"Nuclear imaging modalities for cardiac amyloidosis","volume":"21","author":"Bokhari","year":"2014","journal-title":"J Nucl Cardiol."},{"key":"2023061207251116000_51.2.102.46","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s12350-020-02094-4","article-title":"Cases from busy nuclear cardiology laboratory: potential pitfalls in interpretation of cardiac scintigraphy for ATTR cardiac amyloidosis","volume":"28","author":"Wehbe","year":"2021","journal-title":"J Nucl Cardiol."},{"key":"2023061207251116000_51.2.102.47","first-page":"100268","article-title":"Hydroxychloroquine for COVID-19: curtains close on comedy of errors","volume":"11","author":"Schwartz","year":"2022","journal-title":"Lancet Reg Health Am."},{"key":"2023061207251116000_51.2.102.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.10.015"},{"key":"2023061207251116000_51.2.102.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.07.015"},{"key":"2023061207251116000_51.2.102.50","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.046870"},{"key":"2023061207251116000_51.2.102.51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612"},{"key":"2023061207251116000_51.2.102.52","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.13.001414"},{"key":"2023061207251116000_51.2.102.53","unstructured":"Witteles R . Cardiac amyloidosis. American College of Cardiology website. https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2016\/07\/07\/14\/59\/cardiac-amyloidosis. Published July 7, 2016. Accessed April 19, 2023."},{"key":"2023061207251116000_51.2.102.54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070484"},{"key":"2023061207251116000_51.2.102.55","unstructured":"Messenger RNA (mRNA). National Human Genome Research Institute website. https:\/\/www.genome.gov\/genetics-glossary\/messenger-rna#:\u223c:text=%20role%20of%20mRNA%20is,in%20a%20growing%20protein%20chain. Updated April 18, 2023. Accessed April 19, 2023."},{"key":"2023061207251116000_51.2.102.56","unstructured":"efficacy and safety of AMVUTTRA\u00ae were evaluated in HELIOS-A. Amvuttra website. https:\/\/www.amvuttrahcp.com\/study-design. Accessed April 19, 2023."}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.123.265492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T14:28:39Z","timestamp":1686580119000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.123.265492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6,2]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.2967\/jnmt.123.265492"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.123.265492","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"value":"0091-4916","type":"print"},{"value":"1535-5675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}